Heska $175 million follow-on offering
We advised the joint book-running managers and underwriters on the equity offering
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Cigna $4.3 billion senior notes offering
We advised the underwriters on the investment-grade debt offering
InflaRx $75 million follow-on offering
We advised the underwriters on the equity offering
Adamas Pharmaceuticals $59 million stock offering
We advised the joint book-running managers on the SEC-registered equity offering
AVITA Medical $69.1 million follow-on offering
We advised the underwriters on the equity offering
I-Mab $177 million follow-on secondary offering of ADSs
We advised the underwriters on the equity offering
JOINN Laboratories HK$6.5 billion IPO
We advised JOINN Laboratories on its IPO and HKEX listing.
Ayala Pharmaceuticals $25 million private placement
We advised the placement agent on the private placement of stock and warrants
InnoCare Pharma HK$3.04 billion share placement
We advised InnoCare Pharma in the placement of new shares
New Horizon Health HK$2.04 billion IPO
We advised New Horizon Health on its IPO and HKEX listing